Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-123721
Filing Date
2025-12-22
Accepted
2025-12-22 16:10:23
Documents
1
Period of Report
2025-12-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2534021-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2534021-1_4seq1.xml 4 5287
  Complete submission text file 0001104659-25-123721.txt   6851
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2500 WESTCHESTER AVE PURCHASE NY 10577 412-481-2210
COGNITION THERAPEUTICS INC (Issuer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CHIASMA INC. 140 KENDRICK STREET BUILDING C EAST NEEDHAM MA 20494
Business Address
Doyle John Brendan (Reporting) CIK: 0001840738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40886 | Film No.: 251592540